ClinicalTrials.govpublic full text
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia
newly diagnosed secondary or high risk aml, secondary aml, high risk aml, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914150
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.